BioSpace News Archive

VIVA MEDICARE is expanding into Houston, Henry, Geneva and Dale counties for 2019.

AmeriHealth Caritas, a national leader in Medicaid managed care and other health care solutions for those most in need, announced today the impact of its proprietary Opioid Blueprint

Innate Pharma SA (“Innate” - Euronext Paris: FR0010331421 – IPH), today announced a new multi-term agreement with AstraZeneca, and its global biologics research and development arm MedImmune

Medopad, one of the world’s fastest-growing health technology companies, is today announcing partnerships with leading health tech companies, including Medtronic and Fibricheck

Amgen today announced that its Board of Directors declared a $1.32 per share dividend for the fourth quarter of 2018.

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced it will present new data analyses on the long-term effects of INGREZZA® (valbenazine) capsules in adults with tardive dyskinesia (TD) and from RE-KINECT, the largest real-world screening study of patients with possible TD.

Blueprint Medicines (NASDAQ: BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Tuesday, October 30, 2018 to report its third quarter 2018 financial results and provide a corporate update.

Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the first quarter of fiscal 2019 and hold a conference call to discuss those results on Tuesday, October 30, 2018.

Cryoport, Inc. (NASDAQ: CYRX, CYRXW) (“Company”), the world’s leading temperature-controlled logistics company dedicated to the life sciences industry, today unveiled its newest Global Logistics Center,

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2018 third quarter financial results on Tuesday, November 6, 2018, after the close of the financial markets